The financial vulnerability estimate has increased because of an increase of prescription items dispensed and an uplift in the annual funding settlement.
Emerging trends and prevalent threats
There is a realistic possibility that some pharmacists may be falsely creating referrals via NHS 111 for the urgent supply of medication when the patient had not been seen or made any request for the referral.
£138.49m
vulnerable from an expenditure of £13.85bn
Most popular prescription items mentioned in reporting
It is a realistic possibility that some items claimed for but not dispensed are being shipped overseas or the profits from their sale sent overseas, involving inflammation injections such as Depo-Medrone and Kenalog and anxiety medications such as benzodiazepines.
It is almost certain that prescription items are being claimed for but not dispensed. Recent examples include weight loss medications such as Mounjaro, medications for type 2 diabetes, alongside painkillers and anti-depressants such as co-codamol and amitriptyline respectively.
It is likely that some pharmacies are falsifying patient records. These records may show that a service was provided when it was not, or that a different service was provided. For example, patients receiving a consultation or prescription, such as the Pharmacy First service, when they were just picking up medicine prescribed by the GP.
It is a realistic possibility that some pharmacists are alleged to be appropriating and selling prescribed medication, including fentanyl, pregabalin and diazepam. Part of the motivation for onward selling may be to form a component for another product to be sold in illicit markets. This now extends to selling NHS funded COVID-19 vaccinations to private patients who were otherwise not entitled.
PESTLE analysis
Political: As part of the 10 Year Health Plan, 2026 will see pharmacists having more time to treat patients by expanding those who can supervise the dispensing of medicines. This should assist with managing a higher workload, however opportunities to commit fraud could increase.
Economic: Pharmacy budgets are now subject to clawbacks of £16.8m per quarter to meet the allowed medicine margin, despite wider increases to spending including the Single Activity Fee and expansion of patient services. This may tempt unscrupulous practices if some revenue streams are being reduced.
Social: Expanded pharmacy services, including free emergency contraception and lifestyle-related support, may create opportunities to manipulate patient records or claim for services not conducted or necessary.
Technological: NHSE continues to roll out the ‘GP Connect Access Record: Structured’ system (linking GP practices and pharmacies) which could help expose record manipulation if inconsistencies are noticed by GPs or patients.
Organisational: Sector polling infers that pharmacies have been increasingly operating at a loss over the last decade. The survey also raised medicine supply issues, resulting in compromised care and increased workloads, potentially increasing vulnerability to improper practices.
Media Factors: Public and media attention on pharmacy services is frequent, including coverage of digital prescription tracking tools aimed at reducing pressure on pharmacies.
Reporting
During this reporting period, the NHSCFA received 297 reports compared to last year’s total of 241.
| Thematic area | 2020-21 | 2021-22 | 2022-23 | 2023-24 | 2024-25 | 2025-26 |
|---|---|---|---|---|---|---|
| Pharmaceutical contractor | 107 | 157 | 99 | 203 | 241 | 297 |